A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Year to date metric has recorded a gain of 131.94%.However, over the last six months, we can see a weaker performance of 293.38%. Over the last 30 days, the price of IPA has fallen by 39.69%. And in the last five days, it has fallen by -9.41%.
At present, ImmunoPrecise Antibodies Ltd (IPA) has a stock price of $1.83. In the previous session, the stock saw a rise, peaking at $5.0 after an opening price of $1.83. The day’s lowest price was $3.0, and it closed at $1.64.
The market performance of ImmunoPrecise Antibodies Ltd’s stock has been harmonious in recent times.
52-week price history of IPA Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. ImmunoPrecise Antibodies Ltd’s current trading price is -24.07% away from its 52-week high, while its distance from the 52-week low is 577.78%. The stock’s price range during this time has been between $0.27 and $2.41. The trading volume for the Healthcare sector company’s shares reached about 1.08 million for the day, which was lower than the average daily volume of 2.42 million over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
ImmunoPrecise Antibodies Ltd (IPA) has experienced a quarterly rise of 298.61% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 84.46M and boasts a workforce of 102 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.8276, with a change in price of +1.4306. Similarly, ImmunoPrecise Antibodies Ltd recorded 2,053,308 in trading volume during the last 100 days, posting a change of +358.19%.
IPA’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for IPA stands at 0.57. Similarly, the long-term debt-to-equity ratio is also 0.49.
IPA Stock Stochastic Average
Today’s raw stochastic average for ImmunoPrecise Antibodies Ltd over the last 50 days is 70.00%.This indicates a increase from the raw stochastic average of the past 20 days, which was 38.95%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 33.83% and 40.45%, respectively.
